Article ID Journal Published Year Pages File Type
3332088 Hematology/Oncology Clinics of North America 2007 10 Pages PDF
Abstract
It is important when treating a patient who has advanced breast cancer to establish the biologic characteristics of the tumor. In addition to knowing the hormone receptor status (estrogen and progesterone), human epidermal receptor 2 (HER2) should be evaluated. The measurement of this parameter is essential to optimizing the systemic management. This article reviews the biology of HER2, testing for HER2, clinical studies evaluating HER2-based therapies, side effects (specifically cardiotoxicity), and strategies for HER2-based therapies.
Related Topics
Health Sciences Medicine and Dentistry Hematology
Authors
, ,